Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder
Authors:
- Andrew J. SaxonASAndrew J. Saxon
- Larissa J. MooneyLMLarissa J. Mooney
- Karen MiottoKMKaren Miotto
- Yuhui ZhuYZYuhui Zhu
- Caroline K. YooCYCaroline K. Yoo
- Di LiangDLDi Liang
- David HuangDHDavid Huang
- Douglas S. BellDBDouglas S. Bell
- 1 January 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 13 (1) , 41-46
Abstract
Objective: Prescription Drug Monitoring Programs (PDMPs) are intended to help reduce prescription drug misuse and opioid overdose, yet little is known about the longitudinal patterns of opioid prescribing that may be associated with mortality. This study investigated longitudinal opioid prescribing patterns among patients with opioid use disorder (OUD) and without OUD in relation to mortality using PDMP data. Methods: Growth modeling was used to examine opioid prescription data from the California PDMP for a 4-year period before death or a comparable period ending in 2014 for those remaining from a sample of 7728 patients (2576 with OUD, and 5152 matched non-OUD controls) treated in a large healthcare system. Results: Compared to controls, individuals with OUD (alive and deceased) had received significantly more opioid prescriptions, greater number of days’ supply, and steeper increases of opioid dosages over time. For morphine equivalents (ME, in grams), the interaction of OUD and mortality was significant at both intercept (β = 10.4, SE = 4.4, P < 0.05) and slope (β = 6.0, SE = 1.1, P < 0.001); deceased OUD patients demonstrated the sharpest increase (ie, an average yearly increment of 7.84 grams over alive patients without OUD) and ended with the highest level of opioids prescribed before they died (ie, 20.2 grams higher). Older age, public health insurance, cancer, and chronic pain were associated with higher number and dose of opioid prescriptions. Conclusions: Besides the amount of prescriptions, clinicians must be alert to patterns of opioid prescription such as escalating dosage as critical warning signals for heightened mortality risks, particularly among patients with OUD.Keywords
This publication has 11 references indexed in Scilit:
- High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare SystemJournal of Addiction Medicine, 2017
- Chronic pain among patients with opioid use disorder: Results from electronic health records dataJournal of Substance Abuse Treatment, 2017
- State prescription drug monitoring programs and fatal drug overdoses.2017
- Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014MMWR. Morbidity and Mortality Weekly Report, 2016
- Decline in Drug Overdose Deaths After State Policy Changes — Florida, 2010–20122014
- Prescription drug monitoring and drug overdose mortalityInjury Epidemiology, 2014
- Prescription Drug Monitoring Programs, a Response to Doctor Shopping: Purpose, Effectiveness, and Directions for Future ResearchIssues in Mental Health Nursing, 2012
- Revisiting Paulozzi et al.'s “Prescription Drug Monitoring Programs and Death Rates from Drug Overdose”: Table 1Pain Medicine, 2011
- Prescription Drug Monitoring Programs and Death Rates from Drug OverdosePain Medicine, 2011
- Comorbidity Measures for Use with Administrative DataMedical Care, 1998